According to the bank website, ADB's proposed investment in OAP III is a continuation of its strategy to increase the pace of PSOD investments in health care, as well as an endorsement of OrbiMed as the preferred fund manager given its track record and competitive positioning in the People's Republic of China (PRC) and India, two of Asia''s fastest growing health care markets. OrbiMed's Asia team has successfully deployed capital across 36 portfolio companies through two funds, OrbiMed Asia Partners I, LP Fund (OAP I) and OAP II with respectable exits from OAP I. As a demonstration of its origination skills and recognition of ADB as a value-adding partner, OrbiMed has also offered co-investment opportunities to PSOD, including two hospitals in India and a third hospital opportunity currently being explored in the PRC.
|Private Actor 1||Private Actor 1 Role||Private Actor 1 Sector||Relation||Private Actor 2||Private Actor 2 Role||Private Actor 2 Sector|
|-||-||-||-||OrbiMed Asia GP III, L.P.||Client||-|
Responsible ADB Department Private Sector Operations Department
Responsible ADB Division Private Sector Investment Funds & Special Initiatives Div
Responsible ADB Officer Mahmud, Farshed
ACCOUNTABILITY MECHANISM OF ADB
The Accountability Mechanism is an independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an Asian Development Bank-financed project. If you submit a complaint to the Accountability Mechanism, they may investigate to assess whether the Asian Development Bank is following its own policies and procedures for preventing harm to people or the environment. You can learn more about the Accountability Mechanism and how to file a complaint at: http://www.adb.org/site/accountability-mechanism/main